Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J Marsh

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Materials Chemistry. B|October 22, 2021
An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticlesNidhi Joshi, Dongli Liu, Kristie-Ann Dickson, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2021
Studying the Oncosuppressive Functions of PTENP1 as a ceRNAGlena Travis, Nahal Haddadi, Ann M Simpson, et al.
Human Molecular Genetics|October 25, 2011
The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitinationMichael A Hahn, Kristie-Ann Dickson, Stuart Jackson, et al.
The American Journal of Surgical Pathology|August 26, 2006
Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasiasAnthony J Gill, Adele Clarkson, Oliver Gimm, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidismViive M Howell, John W Cardinal, Anne-Louise Richardson, et al.
Pharmaceutics|April 23, 2022
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer CellsDongli Liu, Gunnar F Kaufmann, James B Breitmeyer, et al.
Cancers|October 14, 2022
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall SurvivalTao Xie, Kristie-Ann Dickson, Christine Yee, et al.
Gynecologic Oncology|November 15, 2017
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancerJaynish S Shah, Gregory B Gard, Jean Yang, et al.
American Journal of Human Genetics|October 21, 2003
Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adultsXiao-Ping Zhou, Deborah J Marsh, Carl D Morrison, et al.
Cancer Letters|August 16, 2015
A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancerLiping Chung, Leo Phillips, Mike Z Lin, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Materials Chemistry. B|October 22, 2021
An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticlesNidhi Joshi, Dongli Liu, Kristie-Ann Dickson, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2021
Studying the Oncosuppressive Functions of PTENP1 as a ceRNAGlena Travis, Nahal Haddadi, Ann M Simpson, et al.
Human Molecular Genetics|October 25, 2011
The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitinationMichael A Hahn, Kristie-Ann Dickson, Stuart Jackson, et al.
The American Journal of Surgical Pathology|August 26, 2006
Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasiasAnthony J Gill, Adele Clarkson, Oliver Gimm, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidismViive M Howell, John W Cardinal, Anne-Louise Richardson, et al.
Pharmaceutics|April 23, 2022
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer CellsDongli Liu, Gunnar F Kaufmann, James B Breitmeyer, et al.
Cancers|October 14, 2022
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall SurvivalTao Xie, Kristie-Ann Dickson, Christine Yee, et al.
Gynecologic Oncology|November 15, 2017
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancerJaynish S Shah, Gregory B Gard, Jean Yang, et al.
American Journal of Human Genetics|October 21, 2003
Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adultsXiao-Ping Zhou, Deborah J Marsh, Carl D Morrison, et al.
Cancer Letters|August 16, 2015
A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancerLiping Chung, Leo Phillips, Mike Z Lin, et al.
Pageof 7